General MedicationsINJECTIONGeneric
SELENOMETHIONINE SE 75
SELENOMETHIONINE SE-75
Standard Dose
100uCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SELENOMETHIONINE SE 75 is listed in Drugs@FDA under application 017098 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SELENOMETHIONINE SE-75 Form and strength INJECTABLE;INJECTION - 100uCi/ML Sponsor MALLINCKRODT Submission history Latest submission status date: 1984-03-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview SELENOMETHIONINE SE 75 is listed in Drugs@FDA under application 017098 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SELENOMETHIONINE SE-75 Form and strength INJECTABLE;INJECTION - 100uCi/ML Sponsor MALLINCKRODT Submission history Latest submission status date: 1984-03-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.